Skip to main content
SpringerLink
Log in

Apixaban vs rivaroxaban in patients with atrial fibrillation

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Fralick M, et al. Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice: A Cohort Study. Annals of Internal Medicine : 10 Mar 2020. Available from: URL: http://dx.doi.org/10.7326/M19-2522

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Apixaban vs rivaroxaban in patients with atrial fibrillation. Reactions Weekly 1796, 7 (2020). https://doi.org/10.1007/s40278-020-76294-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-76294-7

Search

Navigation